Molecular Partners Ag (MOLN) Non Operating Interest Expenses (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Non Operating Interest Expenses for 7 consecutive years, with -$13917.6 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 99.67% year-over-year to -$13917.6 in Q2 2026; TTM through Jun 2026 was -$545782.5, a 93.52% increase from a year earlier, with the FY2025 full-year figure at -$6.1 million, down 13992.79% from the prior year.
• Non Operating Interest Expenses was -$13917.6 for Q2 2026 at Molecular Partners Ag, up from -$14047.1 in the prior quarter.
• Over five years, Non Operating Interest Expenses peaked at $269619.3 in Q1 2022 and troughed at -$4.8 million in Q4 2023.
• A 5-year average of -$881266.6 and a median of -$158707.8 in 2025 frame the typical range for Non Operating Interest Expenses.
• Across the five-year window, Non Operating Interest Expenses sank 38509.45% in 2023 and soared 99.79% in 2024, its largest moves.
• Over 5 years, Non Operating Interest Expenses stood at -$12456.3 in 2022, then slumped by 38509.45% to -$4.8 million in 2023, then soared by 99.79% to -$10273.7 in 2024, then sank by 3029.84% to -$321550.6 in 2025, then surged by 95.67% to -$13917.6 in 2026.
• The last three Non Operating Interest Expenses figures came in at -$13917.6 (Q2 2026), -$14047.1 (Q1 2026), and -$321550.6 (Q4 2025), per Business Quant data.